KELLI ANDERSON: Open Payments
NPI 1447924980 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 83 payments from 17 companies in 2025. Trend: 2023 $1,513 · 2024 $1,768 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $524 |
| GlaxoSmithKline, LLC. | 19 | $286 |
| Viatris Specialty LLC | 13 | $223 |
| United Therapeutics Corporation | 5 | $131 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| GENZYME CORPORATION | 3 | $58 |
| Insmed, Inc. | 3 | $55 |
| Verona Pharma, Inc. | 3 | $53 |
| Philips North America LLC | 2 | $32 |
Products named: YUPELRI, BEVESPI AEROSPHERE, NUCALA, TRELEGY ELLIPTA, Tyvaso, BREZTRI, FASENRA, OFEV.
Industry payments across OK — which companies pay providers there.
